Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence

Breast Cancer Research and Treatment

Volumn 114, Issue 2, 2009, Pages 223-232

  Marques, Ana Rita ^a   Teixeira, Elsa ^a   Diamond, Joana ^a   Correia, Helena ^a   Santos, Sidónia ^a   Neto, Lara ^a   Ribeiro, Manuel ^a   Miranda, Ana ^a   Passos Coelho, José Luís ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Breast cancer; Mammaglobin; Minimal residual disease

Indexed keywords

MAMMAGLOBIN; MESSENGER RNA;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; DISEASE FREE SURVIVAL; FOLLOW UP; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 59449107997     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0002-9     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43-66
2. IJ Diel M Kaufmann SD Costa 1996 Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status J Natl Cancer Inst 88 1652 1658
3. JL Mansi H Gogas JM Bliss 1999 Outcome of primary-breast cancer patients with micrometastases: a long-term follow-up study Lancet 354 197 202
4. EF Solomayer IJ Diel G Salanti 2001 Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients Clin Cancer Res 7 4102 4108
5. W Janni B Rack C Schindlbeck 2005 The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence Cancer 103 884 891
6. M Ignatiadis N Xenidis M Perraki 2007 Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer J Clin Oncol 25 5194 5202
7. M Cristofanilli GT Budd MJ Ellis 2004 Circulating tumor cells, disease progression and survival in metastatic breast cancer N Engl J Med 351 781 791
8. K Pantel RJ Cote O Fodstad 1999 Detection and clinical importance of micrometastatic disease J Natl Cancer Inst 91 1113 1124
9. Carrick S, Parker S, Wilcken N et al (2005) Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev Apr 18, CD003372
10. WG Jiang TA Martin RE Mansel 2002 Molecular detection of micro-metastasis in breast cancer Crit Reev Oncol Hematol 43 13 31
11. K Pantel 1996 Detection of minimal residual disease in patients with solid tumors J Hematother 5 359 367
12. GV Raj JG Moreno LG Gomella 1998 Utilization of polymerase chain reaction technology in the detection of solid tumors Cancer 82 1419 1442
13. AC Lambrechts LJ Van't Veer S Rodenhuis 1998 The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods Ann Oncol 9 1269 1276
14. R Jung K Petersen W Krüger 1999 Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes Br J Cancer 81 870 873
15. P Chamelovier F Mongelard D Seigneurin 1999 CK20 gene expression: technical limits for the detection of circulating tumor cells Anticancer Res 19 2073 2078
16. AL Silva J Diamond MR Silva JL Passos-Coelho 2001 Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues Breast Cancer Res Treat 66 59 66
17. MA Watson TP Fleming 1996 Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer Cancer Res 56 860 865
18. MA Watson S Dintzis CM Darrow 1999 Mammaglobin expression in primary, metastatic and occult breast cancer Cancer Res 59 3028 3031
19. MJ Nuñez-Villar F Martinez-Arribas M Pollán 2003 Elevated mammaglobin (hMAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype Breast Cancer Res. 5 R65 70
20. CJ Min L Tafra KM Verbanac 1998 Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes Cancer Res 58 4581 4584
21. E Leygue L Snell H Dotzlaw 1999 Mammaglobin, a potential marker of breast cancer nodal metastasis J Pathol 189 28 33
22. M Mitas K Mikhitarian C Walters 2001 Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel Int J Cancer 93 162 171
23. BK Zehentner DC Dillon Y Jiang 2002 Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementarity transcribed genes in breast cancer lymph nodes Clin Chem 48 1225 1231
24. JH Han Y Kang HC Shin 2003 Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma Arch Pathol Lab Med 127 1330 1334
25. WE Gillanders K Mikhitarian R Hebert 2004 Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study Ann Surg 239 828 840
26. O Zach H Kasparu O Krieger 1999 Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA J Clin Oncol 17 2015 2019
27. N Cerveira L Torres P Rocha 2004 Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients Int J Cancer 108 592 595
28. AL Silva MJ Tomé AE Correia JL Passos-Coelho 2002 Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products Ann Oncol 13 422 429
29. Diamond J, Goldman JM, Melo JV (1995) BCR-ABL, ABL-BCR, BCR and ABL genes are all expressed in chronic myeloid leukemia. Blood 85:2171-2175
30. A Ring IE Smith M Dowsett 2004 Circulating tumour cells in breast cancer Lancet Oncol 5 79 88
31. AM Vannucchi A Bosi S Glinz 1998 Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA Br J Hematol 103 610 617
32. DN Krag T Ashikaga TJ Moss 1999 Breast cancer cells in the blood: a pilot study Breast J 5 354 358
33. AM Gilbey D Burnett RE Coleman I Holen 2004 The detection of circulating breast cancer cells in blood J Clin Pathol 57 903 911
34. N O'Brien TM Maguire N O'Donovan 2002 Mammaglobin: a promising marker for breast cancer Clin Chem 48 1362 1364
35. K Grunewald M Haun M Urbanek 2000 Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19 Lab Invest 80 1071 1077
36. B Suchy F Austrup G Driesel 2000 Detection of mammaglobin expressing cells in blood of breast cancer patients Cancer Lett 158 171 178
37. BK Zehentner D Carter 2004 Mammaglobin: a candidate diagnostic marker for breast cancer Clin Biochem 37 249 257
38. WH Krüger R Jung B Detlefsen 2001 Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells Med Oncol 18 33 38
39. K Grunewald M Haun M Fiegl 2002 Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction Lab Invest 82 1147 1153
40. A Sjödin D Guo PA Hofer 2003 Mammaglobin in normal human sweat glands and human sweat gland tumors J Invest Dermatol 121 428 429
41. M Ntoulia A Stathopoulou M Ignatiadis 2006 Detection of mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR Clin Biochem 39 879 887
42. S Roncella P Ferro B Bacigalupo 2005 Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood J Exp Clin Cancer Res 24 265 271
43. SA Bustin V Benes T Nolan MW Pfaffl 2005 Quantitative real-time RT-PCR-a perspective J Mol Endocrinol 34 597 601
44. G Gargano V Agnese V Calo 2006 Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) a prospective study Ann Oncol 17 Suppl 7 vii41 vii45
45. YC Lin SC Chen S Hsueh 2003 Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients Cancer Sci 94 99 102
46. DJ Slamon GM Clark SG Wong 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogenes Science 235 177 182
47. K Mikhitarian RH Martin MB Ruppel 2008 Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study BMC Cancer 8 55
48. G Méhes A Witt E Kubista PF Ambros 2001 Circulating breast cancer cells are frequently apoptotic Am J Pathol 159 17 20
49. RA Saez WL Mc Guire GM Clark 1989 Prognostic factors in breast cancer Semin Surg Oncol 5 102 110
50. T Nemoto N Natarjan R Bedwani 1983 Breast cancer in the medial half: results of the 1978 national survey of the American College of Surgeons Cancer 51 1333 1338
51. K Pantel RH Brakenhoff 2004 Dissecting the metastatic cascade Nat Rev Cancer 4 448 456
52. Zlotnik A (2004) Chemokines in neoplastic progression. Semin Cancer Biol 181-185
53. H Wiley E Gonzalez W Maki 2001 Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma J Natl Cancer Inst 93 1588 1589
54. T Murakami W Maki AR Cardones 2002 Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cancer cells Cancer Res 62 7328 7334
55. LM McShane DG Altman W Sauerbrei 2006 REporting recommendations for tumor MARKER prognostic studies (REMARK) Breast Cancer Res Treat 100 229 235